A Case of Cervical Cancer that Healed Completely after Surgical Extirpation and Prevention of Recurrence with Oral Intake of 4-Hydroxybenzaldehyde

Okazaki K

Published on: 2019-09-20

Abstract

In 1985, Mutsuyuki Kochi reported a novel anti-tumor agent [1] after acquiring a Japanese Patent in 1969 [2]. According to his patent, 4-Hydroxybenzaldehyde is a water-soluble anti-tumor agent without any side-effects. Mostly, so called anti-tumor agents are incapable of ceasing carcinogenesis. In other words, they are only able to control multiplications of malignant tumor cells. Still in other words, they inhibit divisions of malignant cells. Therefore, they cannot be used for cancer prevention.